GE HealthCare stock holds near $64 after upbeat July results

Published on 09/11/2026 at 20:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

GE HealthCare stock traded at $64.24 on September 10, 2026, with a $77.73 consensus target. July 29, 2026 revenue was $5.29 billion and EPS was $1.13.

Techniker bedient MRT-Scanner in hellem Krankenhaus-Untersuchungsraum mit Flurblick — GE HealthCare US36266G1076 zeigt einen modernen MRT-Scanner im hellen klinischen Krankenhaus mit Techniker, Illustration mit AI erstellt.

GE HealthCare stock (US36266G1076) closed at $64.24 on the NYSE on September 10, 2026, after a 1.43 percent drop. MarketBeat pegs the shares at a $77.73 consensus target and a Hold rating, implying 21.0 percent upside from the same snapshot.

July earnings set the tone

According to MarketBeat on September 11, 2026, GE HealthCare reported $1.13 in EPS for the quarter and $5.29 billion in revenue on July 29, 2026. The portal said revenue rose 5.8 percent year over year, while EPS beat the $1.04 consensus by $0.09.

The same source said net margin was 9.33 percent and return on equity was 20.12 percent for that quarter. For investors, the gap between $1.13 EPS and the $1.04 estimate is the clearest near-term signal.

Consensus stays cautious

According to MarketBeat on September 11, 2026, GE HealthCare has 10 Buy ratings and 11 Hold ratings among 21 analysts. The same page lists a low target of $14.00 and a high target of $98.00, with average upside of 21.0 percent from $64.24.

The stock's 52-week range stands at $58.75 to $89.77, and volume reached 184,820 shares in the same snapshot. That keeps the share price below the top of the range, but not far from the lower end of the recent band.

Price and range

GE HealthCare stock ended September 10, 2026 at $64.24 on the NYSE, with a prior close of $64.42 and a daily move of -1.43 percent. Market capitalization was $28.83 billion in the same MarketBeat snapshot.